ANTI-SYNTHETASE SYNDROME
Clinical trials for ANTI-SYNTHETASE SYNDROME explained in plain language.
Never miss a new study
Get alerted when new ANTI-SYNTHETASE SYNDROME trials appear
Sign up with your email to follow new studies for ANTI-SYNTHETASE SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
One-Shot cell therapy aims to reset immune system in devastating muscle diseases
Disease control Recruiting nowThis study is testing a one-time cell therapy called CABA-201 for adults and children with rare autoimmune diseases that cause severe muscle weakness and inflammation. The goal is to see if this treatment can safely reduce disease activity and improve muscle strength, potentially…
Matched conditions: ANTI-SYNTHETASE SYNDROME
Phase: PHASE2, PHASE3 • Sponsor: Cabaletta Bio • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Patients take the mic: global study asks what myositis research really matters
Knowledge-focused Recruiting nowThis study aims to understand what research topics are most important to people living with rare inflammatory muscle diseases called myositis. Researchers will gather opinions from about 700 patients and caregivers worldwide through online surveys, stories, and group discussions.…
Matched conditions: ANTI-SYNTHETASE SYNDROME
Sponsor: Myositis International Health & Research Collaborative Alliance Foundation • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:30 UTC